Clinical Trials Browser

Interventional × Hepatocellular Carcinoma Non-resectable × Gastrointestinal × Clear all

NCT05797870 2026-03-19

Lip-Re2

Phase 2 Suspended

Gastrointestinal

Hepatocellular Carcinoma Non-resectable

NCT05530785 2022-09-07

Radiotherapy + Sintilimab + Bevacizumab Biosimilar for uHCC With PVTT

Phase NA Unknown

Gastrointestinal

Hepatocellular Carcinoma Non-resectable